IN2014MN01377A - - Google Patents

Info

Publication number
IN2014MN01377A
IN2014MN01377A IN1377MUN2014A IN2014MN01377A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A IN 1377MUN2014 A IN1377MUN2014 A IN 1377MUN2014A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A
Authority
IN
India
Prior art keywords
amorphous precipitated
protein
dry
protein particles
precipitated protein
Prior art date
Application number
Inventor
Jan Vos
Andrew John Macleod
Barry Douglas Moore
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Publication of IN2014MN01377A publication Critical patent/IN2014MN01377A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to the provision of a novel method for preparing dry amorphous precipitated protein particles. In particular to a method provides amorphous precipitated protein particles suitable for use in dry protein formulations which can be reconstituted to provide clear foam free concentrated protein solutions.
IN1377MUN2014 2011-12-23 2012-12-24 IN2014MN01377A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201122408A GB201122408D0 (en) 2011-12-23 2011-12-23 Method for preparing dry protein formulations
PCT/GB2012/053265 WO2013093524A2 (en) 2011-12-23 2012-12-24 Method for preparing amorphous precipitated protein particles

Publications (1)

Publication Number Publication Date
IN2014MN01377A true IN2014MN01377A (en) 2015-04-17

Family

ID=45695047

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1377MUN2014 IN2014MN01377A (en) 2011-12-23 2012-12-24

Country Status (9)

Country Link
US (1) US20140348852A1 (en)
EP (1) EP2793863B1 (en)
JP (1) JP2015500869A (en)
BR (1) BR112014015357A2 (en)
CA (1) CA2859288A1 (en)
DK (1) DK2793863T3 (en)
GB (1) GB201122408D0 (en)
IN (1) IN2014MN01377A (en)
WO (1) WO2013093524A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11174458B2 (en) * 2007-04-23 2021-11-16 Koligo Therapeutics, Inc. Cell separation apparatus and methods of use
GB201313368D0 (en) * 2013-07-26 2013-09-11 Xstalbio Ltd Novel Reconstitution devices
EP4545070A3 (en) 2016-11-22 2025-06-18 Elektrofi, Inc Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
US11077059B2 (en) 2017-07-25 2021-08-03 Elektrofi, Inc. Electrospraying formation of particles including agents
CA3097059A1 (en) * 2018-04-16 2019-10-24 Merck Patent Gmbh Method for stabilizing protein comprising formulations by using a meglumine salt
KR20210021299A (en) 2018-05-10 2021-02-25 리제너론 파아마슈티컬스, 인크. Formulation containing high concentration VEGF receptor fusion protein
US12115262B2 (en) 2018-05-24 2024-10-15 Elektrofi, Inc. Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
EP3917500A2 (en) 2019-01-31 2021-12-08 Elektrofi, Inc. Particle formation and morphology
EP3921082A4 (en) * 2019-02-05 2022-11-02 Lindy Biosciences, Inc. ISOLATED CELL CULTURE COMPONENTS AND METHODS OF ISOLATION THEREOF FROM LIQUID CELL CULTURE MEDIUM
WO2021212019A1 (en) 2020-04-17 2021-10-21 Elektrofi, Inc. Methods of forming particles by continuous droplet formation and dehydration
CN115844752B (en) * 2022-11-02 2024-06-28 上海铂舍生物科技有限公司 A 5D supramolecular collagen and its preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0300427D0 (en) 2003-01-09 2003-02-05 Univ Strathclyde Pharmaceutical composition
GB0707938D0 (en) * 2007-04-25 2007-05-30 Univ Strathclyde Precipitation stabilising compositions

Also Published As

Publication number Publication date
EP2793863A2 (en) 2014-10-29
US20140348852A1 (en) 2014-11-27
CA2859288A1 (en) 2013-06-27
BR112014015357A2 (en) 2017-07-11
WO2013093524A3 (en) 2013-08-15
EP2793863B1 (en) 2018-07-25
JP2015500869A (en) 2015-01-08
GB201122408D0 (en) 2012-02-08
DK2793863T3 (en) 2018-11-12
WO2013093524A2 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
IN2014MN01377A (en)
EP2773746A4 (en) Adult mesenchymal stem cell (msc) compositions and methods for preparing the same
GB201213868D0 (en) Improvements in or relating to methods of manufacture
MY166059A (en) Fusion Proteins for Treating Metabolic Disorders
ZA201403109B (en) Modulating beta-damascenone in plants
MY168396A (en) Smoking article comprising menthol
EP2529006A4 (en) Methods&compositions for improving protein production
PT2665818T (en) Protein expression in plants
PL2768935T3 (en) Formulations, use thereof as or to produce dishwashing detergents, and production thereof
AU340459S (en) Teat for baby bottle
HUE047737T2 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
EP2697640A4 (en) Method for profiling phytohormone levels in plant tissue
EP2663288A1 (en) Methods for preparing vesicles and formulations produced therefrom
ZA201300275B (en) Methods for producing proteins in plants
ZA201403059B (en) Increasing virus-like particle yield in plants
IL230519B (en) Virus-based vector compositions useful for transducing eukaryotic cells
GB201115472D0 (en) Improvements in or relating to wheels
ZA201404560B (en) Process for preparing sodium bicarbonate particles
IN2015DN04074A (en)
PL2714327T3 (en) Improvements in knife sharpening methods
HUE038004T2 (en) Means and methods to induce apomixis in plants
MX351994B (en) Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5 -carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl]-amide.
PH12014500432A1 (en) Stable compositions and methods for preparing the same
IN2012CH02984A (en)
GB201119652D0 (en) Improvements in or relating to subsea power distribution